ReNAgade Therapeutics Launches with over $300 Million in Series A Financing To Unlock the Limitless Potential of RNA Medicine
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines to correct disease, today announced a $300 million Series A financing round led by MPM BioImpact and F2 Ventures.
ReNAgade has built a comprehensive and complementary platform that combines its proprietary delivery technologies, including novel lipid nanoparticles (LNPs), with a broad array of coding, editing, and gene insertion tools, in an all-RNA system. ReNAgade aims to address major limitations in RNA therapeutics by enabling the delivery of RNA medicines to previously inaccessible tissues and cells in the body, substantially expanding the potential addressable disease market. The Company has an established Joint Venture with Orna Therapeutics Inc., combining ReNAgade’s delivery platform with Orna’s circular RNA technology. Subsequently, Orna has entered into a collaboration with Merck, which includes technologies developed under the Orna/ReNAgade JV.
“ReNAgade was founded on a bold idea – to dramatically transcend the boundaries of RNA medicine, a field that has made great strides but remains in its infancy,” said Ansbert Gadicke, M.D., Managing Partner of MPM Bioimpact and Founder of ReNAgade. “By innovating on delivery technology and bringing an array of genomic medicine tools under one roof, ReNAgade is poised to deliver RNA to organs and tissues not previously accessible. ReNAgade’s joint venture with Orna provides early validation of the technologies that ReNAgade will continue to bring forward.”
Founded by MPM BioImpact, ReNAgade is led by Chairman and Chief Executive Officer Amit D. Munshi, an industry veteran with more than 30 years of experience leading biotech companies and most recently the CEO of Arena Pharmaceuticals, with support from a world-class executive and scientific team with deep, translational expertise across multiple RNA modalities. Pete Smith, Ph.D., Chief Scientific Officer and an Executive Partner at MPM BioImpact, joins from Alnylam having previously served as Chief Early Development Officer and prior to that Senior Vice President and Head of R&D Nonclinical at Moderna, while Ciaran Lawlor, Ph.D., joins as Chief Operating Officer from Boston Consulting Group, having previously held multiple scientific roles at Moderna. Brian Shuster joins as Chief Business Officer from Bristol Myers Squibb. Brian previously worked at Johnson & Johnson where he led acquisitions, divestitures and equity investing, and at J.P. Morgan, where he worked with biotech companies on strategic and financing transactions.
“In order to fulfill our mission to develop RNA medicines with the potential to treat any disease anywhere in the body, we have curated a world-class, multidisciplinary team who have collectively achieved 25 NDAs, including four in RNA medicines, and 200 INDs, and have been pioneers in the field of RNA medicines,” said Amit D. Munshi, Chief Executive Officer of ReNAgade. “We are further buoyed by the support of our long-term investors and validated by the progress we have made to date – making us well-positioned to expand the reach of RNA medicine far beyond what was previously thought possible.”
About ReNAgade Therapeutics
ReNAgade exists to unlock the potential for RNA medicines to treat disease anywhere in the body. We combine our novel RNA delivery platforms with a comprehensive RNA platform allowing for an all-RNA system for coding, editing and gene insertion to develop new medicines.
To accelerate the future of medicine, we bring together a team with deep RNA and delivery expertise to develop paradigm-shifting RNA medicines.
ReNAgade Therapeutics – RNA Without Limits
For more information about the company, its technologies, and its leadership, visit https://www.renagadetx.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230523005422/en/
Emily Brabbit, Argot Partners
Sarah Sutton, Argot Partners
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
The LYCRA Company’s Sustainability Director Joins Panel Discussion at the United Nations Conscious Fashion and Lifestyle Network Annual Meeting31.5.2023 12:00:00 EEST | Press release
The LYCRA Company, a global leader in developing innovative and sustainable fiber and technology solutions for the apparel and personal care industries, announced today that it is a supporting partner of the United Nations Conscious Fashion and Lifestyle Network Annual Meeting on June 1. The company’s sustainability director, Jean Hegedus, will be a panelist at the meeting taking place at the United Nations Headquarters in New York City that will bring together media, industry stakeholders, and United Nations representatives to highlight actions, solutions, and progress from the fashion and lifestyle sectors to advance knowledge and strengthen engagement of the Sustainable Development Goals. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230531005027/en/ The LYCRA Company’s sustainability director, Jean Hegedus, joins a panel discussion at the United Nations Conscious Fashion and Lifestyle Network Annual Meeting, which takes
Brussels Signal: New Media Outlet Promises to Shake Up EU Coverage31.5.2023 11:03:00 EEST | Press release
Digital publisher Remedia Europe is preparing a groundbreaking news outlet, Brussels Signal , that promises to provide fresh and candid coverage of EU affairs and the issues that matter most to the citizens of Europe. Brussels Signal will deliver rigorous reporting and analysis of the European Union. The news outlet aims to shake up the status quo by providing insightful and informed journalism that challenges prevailing ideas and policies, demands genuine accountability from decision-makers, and counters the marginalisation of dissenting voices on the issues facing Europe today. An early version of Brussels Signal opens May 31 with an invitation to join a live event with the new editors. Other features of the news outlet – including video content and newsletters – will roll out in the coming weeks, with events coming this autumn at the Brussels Signal’s purpose-built studio in the heart of the European Quarter of Brussels. The new media brand emerges at a time when the EU faces intern
Norwegian ISP Altibox chooses Alinto's secure email platform to provide messaging services to its clients31.5.2023 11:00:00 EEST | Press release
Norwegian ISP Altibox has decided to outsource its email platform to Alinto, with the aim of modernising its messaging services for 180 000 clients in the Nordics. The services provided are based on the SOGomail server and the Cleanmail security service, hosted by Alinto. This move happens a few months after the takeover of the SOGo open-source project by Alinto. It confirms the editors’ ability to address projects on an international scale and cover the whole email chain with GDPR-compliant solutions. Modernisation of an email platform used by 180 000 clients Until 2022, Altibox had a messaging platform built and operated in-house. As that platform started to require extensive maintenance operations, Altibox had to move to a new solution. "We had two options : discontinue the service and delete all the emails – which was not acceptable from a client standpoint, or outsource our email services as we did not have any internal resources to create a new solution”, Marius Ekeland explains.
MDS Global Launches an AI-powered Marketing Decision Intelligence Platform “MDS DecisionAI” That Enables Telcos to Reduce Churn and Increase Revenues31.5.2023 09:22:00 EEST | Press release
Today, MDS Global, a leading provider of converged B2B/B2C billing and BSS solutions, has launched MDS DecisionAI, a new marketing decision intelligence platform that leverages the power of artificial intelligence to provide the critical insight ambitious MNOs, MVNOs, sub-brands and fixed line operators need to grow and outperform the competition. MDS DecisionAI provides a full suite of telecoms specific AI modules including forecasting, churn, propensity models, and marketing and media mix analysis, that will help brands to optimise their marketing and commercial strategy. It enables them to identify monetisation opportunities and blind spots so they can make interventions sooner. As a result, operators will be able to maximise yield and revenue, for example by predicting churn and identifying a customer’s propensity to consider other products offered in a cross-sell campaign, or through better-informed proposition development. As part of MDS Global’s commitment to driving profitable
Gcore Makes Its Managed Kubernetes Service Available On Bare Metal31.5.2023 09:04:00 EEST | Press release
Gcore — a European provider of high-performance, low-latency, international cloud, and edge solutions — today announces the launch of major updates to its Managed Kubernetes service. Customers using the service can now run containers on bare metal servers in addition to using virtual machines (VMs). Running containers directly on bare metal operating systems improves latency and performance as well as removes interference from neighbouring VMs. The implementation is based on Kubernetes' Cluster API and comes with a high availability and uptime guarantee service level agreement (SLA). Seva Vayner, Director of Edge Cloud stream at Gcore, comments: “Most cloud vendors only support Kubernetes containers in VM-based infrastructure. Yet businesses in majority of industries as banking, healthcare, broadcasting, and gaming, among others, increasingly require an edge to support real-time applications and live-streaming graphics. That's where Gcore comes in. Our new bare metal service unlocks lo
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom